Author:
Le Guyader N.,Auvrignon A.,Vu-Thien H.,Portier E.,Tabone M. D.,Leverger G.
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Arguedas A, Sifuentes-Osornio J, Loaiza C, Herrera M, Corrales JC, Mohs E (1996) An open, multicenter clinical trial of piperacillin-tazobactam in the treatment of pediatric patients with intra-abdominal infection. J Chemother 8:130?136
2. Bauduer F, Cousin T, Boulat O, Rigal-Huguet F, Molina L, Fegueux N, Jourdan E, Boiron JM, Reiffers J (2001) BGMT Collaborative Group. A randomized prospective multicentric trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia. Leuk Lymphoma 42:379?386
3. Cometta A, Zinner S, de Bock R, Calandra T, Gaya H, Klastersky J, Langenaeken J, Paesmans M, Viscoli C, Glauser MP (1995) Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empirical therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 39:445?452
4. Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, Moreau P, Ladeb S, Nalet V, Rollin C, Gres JJ (1997) Cefepime-amikacin vs ceftazidime-amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. Clin Infect Dis 24: 41?51
5. De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP (1999) Ceftazidime compared with piperacillin-tobramycin for the empiric treatment of febrile neutropenic patients with cancer. Ann Intern 120:834?844
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献